Images
Participants
![](/sites/default/files/styles/medium_220px_width/public/migrated/researchers/images/serrano_serrano_2.jpg?itok=ugLx93AL)
Contact
![](/sites/default/files/styles/medium_220px_width/public/2020-11/nahiaprueba_0.jpg?itok=lGhKXjfl)
La Vanguardia, La Razón, Diario Médico, among other media, have highlighted the recognition given to Manuel Serrano, ICREA Research professor and group leader of the Cellular Plasticity and Disease Lab at IRB Barcelona, for his work "Tissue damage and senescence provide critical signals for reprogramming cellular in vivo". He has been distinguished with the Severo Ochoa Prize for Biomedial Research. It is a project financed by CaixaImpulse, a program of "la Caixa" Bank Foundation and Caixa Capital Risc.
Selected media:
Link to La Vanguardia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).